Develops drugs for solid tumors and other serious diseases.
Jun 2026Revenue $100K/yrExpenses $16.5M/yr
No trendCash runway ≈ 10 months from Jun 2026
Figures by year
When will Lisata Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $100K and expenses $16.5M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $170K | $18.4M | −$18.2M |
| Dec 2024 | $1.00M | $23.4M | −$22.4M |
| Dec 2023 | $0.00 | $25.7M | −$25.7M |
| Dec 2022 | $0.00 | $57.6M | −$57.6M |
| Dec 2016 | $35.3M | $64.8M | −$29.5M |
| Dec 2015 | $22.5M | $136M | −$114M |
| Dec 2014 | $17.9M | $75.7M | −$57.7M |
| Dec 2013 | $14.7M | $51.5M | −$36.8M |
| Dec 2012 | $14.3M | $44.7M | −$30.4M |
| Dec 2011 | $10.1M | $44.1M | −$34.0M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.